UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Learn the key factors that contribute to a reliable dividend stock. Make informed investment choices for steady income.
20,247 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Adobe's 2026 earnings trajectory hinges on subscription momentum, AI-enabled products, and disciplined costs. This gu...
Markets swing, but smart investors seek durable growth. This article highlights three names with a credible path to m...
During 13F season, big investors reveal shifts in their portfolios. This piece explains the move, why Microsoft was f...
SpaceX is inching toward a public listing that could expose who truly owns private stakes and how that ownership tran...
Oil prices sprint higher, then pull back, leaving investors on edge. This piece explains how those moves could push i...
AMD and Nvidia lead the AI GPU wave, but they aren’t identical bets. This guide breaks down how to compare them, with...
Oracle stock faces a pivotal moment as management doubles down on AI infrastructure while financing plans raise dilut...
As Berkshire Hathaway enters a new chapter, investors wonder if berkshire's just break from Buffett's time-tested pla...
Youdao is at a crossroads as AI and education tech intersect. This guide breaks down what to expect from youdao (dao)...
If you’re wondering whether you should invest DRAM right now, this guide breaks down the drivers, risks, and a practi...
Investors are watching a handful of tech names retreat despite strong long term potential. This guide explains how be...